APA (7th ed.) Citation

KG, X., JF, K., TS, L., QB, L., & KY, K. (2026). Serum mir-181a as a potential serological biomarker for metabolic dysfunction-associated fatty liver disease: A cross sectional study. Medicine, 105(4), e47290. https://doi.org/10.1097/MD.0000000000047290

Chicago Style (17th ed.) Citation

KG, Xiong, Kong JF, Lin TS, Lin QB, and Ke KY. "Serum Mir-181a as a Potential Serological Biomarker for Metabolic Dysfunction-associated Fatty Liver Disease: A Cross Sectional Study." Medicine 105, no. 4 (2026): e47290. https://doi.org/10.1097/MD.0000000000047290.

MLA (9th ed.) Citation

KG, Xiong, et al. "Serum Mir-181a as a Potential Serological Biomarker for Metabolic Dysfunction-associated Fatty Liver Disease: A Cross Sectional Study." Medicine, vol. 105, no. 4, 2026, p. e47290, https://doi.org/10.1097/MD.0000000000047290.